-
Milestone Pharmaceuticals Announces Resubmission of New Drug Application for Etripamil for Treatment in Paroxysmal Supraventricular Tachycardia
28 Mar 2024 11:00 GMT
… Officer of Milestone Pharmaceuticals. “If approved … Pharmaceuticals Milestone Pharmaceuticals Inc. (Nasdaq: MIST) is a biopharmaceutical company developing … designed," "develop," "estimate … biopharmaceutical product development and clinical …
-
The Playful Path To Development: Unravelling The Benefits Of Baby Play Mats
28 Mar 2024 11:02 GMT
Are you looking for a fun and interactive way to support your baby’s development? Look no further than baby play mats! These colorful and engaging mats provide a playful path to growth and learning for your little one. In this blog post, we’ll explore the …
-
“The pharmacy of the world is ceding ground to Asian rivals,” Bernstein analysts in open letter to PM
28 Mar 2024 09:53 GMT
… in from investors and Big Pharma in the form of M … per cent would be developed in India. “For pharmaceutical companies, the economics … quite telling that the largest pharma company in India has chosen … often referred to as the ‘pharmacy of the world’ and the …
-
Timing of Pubertal Development Tied to Adult Cardiometabolic Risk
28 Mar 2024 08:34 GMT
WEDNESDAY, March 27, 2024 (HealthDay News) — Pubertal development and its timing may be an important pathway through which early-life exposures shape adulthood cardiometabolic health and disease, according to a study published online March 27 in PLOS ONE.
…
-
~60 per cent of Indian pharmaceutical industry to grow by 8-10 per cent in FY2025
28 Mar 2024 09:53 GMT
… of the Indian pharmaceutical companies remain healthy, … to sustain, Indian pharmaceutical companies remain focused … revenue driver, any developments favouring genericisation and inclusion … acquisitions by Indian pharmaceutical companies in recent quarters …
-
ACC: Short Sleep Duration Linked to Risk of Developing Hypertension
28 Mar 2024 08:34 GMT
WEDNESDAY, March 27, 2024 (HealthDay News) — Short sleep duration is associated with an increased risk of developing hypertension, according to a study scheduled for presentation at the annual meeting of the American College of Cardiology, held from April …
-
Konstant Splashes Python Code over All Web Developers
28 Mar 2024 11:13 GMT
Python is equivalent to data science, AI, ML, data analytics, and robotics. That’s probably the reason Konstant does it, and strives to excel at it!
UNITED STATES, March 28, 2024 /EINPresswire.com/ -- Everyone expects and eagerly anticipates the …
-
Monopar Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Developments
28 Mar 2024 11:00 GMT
WILMETTE, Ill., March 28, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients, today announced fourth quarter and full-year 2023 …
-
Aldeyra Therapeutics Announces Clinical Development Plan for Resubmission of New Drug Application for Reproxalap in Dry Eye Disease
28 Mar 2024 11:21 GMT
… to discovering and developing innovative therapies designed … announced the clinical development plan intended to enable … Our approach is to develop pharmaceuticals that modulate protein systems … to establish and maintain development partnerships; Aldeyra’s …
-
Sagah confident vaccine will be developed to fight rabies
28 Mar 2024 10:54 GMT
… expertise in biomedical matters and pharmaceutical product manufacturing.
The SIDC, a … globally, with a focus on developing diagnostics, therapeutics and vaccines.
Sagah … significant milestone for the SIDC development project, signalling the commencement of …